The Assessment Group

The Assessment Group (TAG) is a specialized market access and pricing consultancy serving the global pharmaceutical and biotechnology industries. The company provides strategic guidance on value demonstration, reimbursement, and commercialization strategies to ensure successful product launches. TAG's expertise includes payer research, pricing analysis, and the development of value propositions for diverse healthcare stakeholders. Following its acquisition by Precision Medicine Group, it operates as part of the Precision Value & Health division, leveraging data-driven insights to navigate complex global market access landscapes. The firm is recognized for its ability to translate clinical data into compelling economic arguments for payers and health systems.